|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,999.00 JPY | +2.21% |
|
-5.38% | -15.09% |
| 07-24 | Chugai Pharmaceutical Co., Ltd., Q2 2026 Earnings Call, Jul 24, 2026 | |
| 07-24 | Chugai Pharmaceutical's H1 Profit Jumps 19% | MT |
| Market Cap | 11,267B 68.84B 60.52B 56.33B 51.74B 97.15B 6,602B 98.43B 670B 262B 3,260B 258B 253B | P/E 2026 * |
22.2x | P/E 2027 * | 19x |
|---|---|---|---|---|---|
| Enterprise Value | 10,263B 62.71B 55.12B 51.31B 47.12B 88.49B 6,013B 89.66B 610B 238B 2,969B 235B 230B | EV / Sales 2026 * |
7.39x | EV / Sales 2027 * | 6.59x |
| Free-Float |
38.12% | Yield 2026 * |
1.99% | Yield 2027 * | 2.3% |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | +2.21% | ||
| 1 week | -5.38% | ||
| Current month | -7.10% | ||
| 1 month | -7.59% | ||
| 3 months | -11.85% | ||
| 6 months | -17.14% | ||
| Current year | -15.09% |
| 1 week | 6,795 | 7,509 | |
| 1 month | 6,795 | 7,939 | |
| Current year | 6,795 | 10,700 | |
| 1 year | 5,942 | 10,700 | |
| 3 years | 4,076 | 10,700 | |
| 5 years | 3,191 | 10,700 | |
| 10 years | 1,003.33 | 10,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 63 | 01/03/2021 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | 59 | 28/03/2024 |
Kazuhiko Nishi
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
BRD | Director/Board Member | 63 | 01/03/2020 |
Iwaaki Taniguchi
BRD | Director/Board Member | 59 | 28/03/2024 |
| Director/Board Member | 51 | 01/03/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.21% | -5.38% | -5.79% | +69.63% | 68.84B | ||
| +0.13% | +4.41% | +47.35% | +163.20% | 1,068B | ||
| +0.97% | +6.88% | +58.02% | +53.12% | 641B | ||
| -0.94% | +1.39% | +35.02% | +72.60% | 454B | ||
| +0.03% | +7.79% | +38.07% | +33.56% | 351B | ||
| +0.02% | +2.07% | +37.28% | +41.98% | 299B | ||
| -1.32% | +1.36% | +17.34% | +14.50% | 266B | ||
| +0.45% | +0.88% | -27.54% | -38.13% | 220B | ||
| +0.06% | +3.32% | +22.73% | +59.40% | 203B | ||
| +0.94% | -2.02% | +12.32% | +70.59% | 162B | ||
| Average | +0.24% | +1.83% | +23.48% | +54.04% | 373.22B | |
| Weighted average by Cap. | +0.10% | +2.68% | +35.62% | +77.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,389B 8.49B 7.46B 6.95B 6.38B 11.98B 814B 12.14B 82.58B 32.25B 402B 31.87B 31.18B | 1,539B 9.4B 8.27B 7.69B 7.07B 13.27B 902B 13.44B 91.45B 35.72B 445B 35.29B 34.53B |
| Net income | 507B 3.1B 2.73B 2.54B 2.33B 4.37B 297B 4.43B 30.15B 11.78B 147B 11.64B 11.39B | 592B 3.62B 3.18B 2.96B 2.72B 5.11B 347B 5.17B 35.2B 13.75B 171B 13.59B 13.29B |
| Net Debt | -1,004B -6.14B -5.39B -5.02B -4.61B -8.66B -588B -8.77B -59.68B -23.31B -291B -23.03B -22.53B | -1,120B -6.84B -6.01B -5.6B -5.14B -9.66B -656B -9.78B -66.55B -25.99B -324B -25.68B -25.13B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/07/26 | ¥6,999.00 | +2.21% | 4,135,500 |
| 27/07/26 | ¥6,848.00 | -7.66% | 6,311,000 |
| 24/07/26 | ¥7,416.00 | +2.83% | 2,827,400 |
| 23/07/26 | ¥7,212.00 | -1.29% | 2,609,800 |
| 22/07/26 | ¥7,306.00 | -1.23% | 2,064,700 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4519 Stock
Select your edition
All financial news and data tailored to specific country editions


















